Keryx Biopharmaceuticals, Inc. et al v. Watson Laboratories, Inc. et al
| Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc. |
| Watson Laboratories, Inc., Teva Pharmaceutical Industries Limited and Teva Pharmaceuticals USA, Inc. |
| 2:2019cv00837 |
| May 15, 2019 |
| US District Court for the District of Nevada |
| Richard F Boulware |
| Nancy J Koppe |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 145 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 5, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 7 AO 120 - REPORT on the filing or determination of an action regarding a patent or trademark. E-mailed to the US Patent and Trademark Office. (JM) |
| Civil Case Terminated pursuant to #6 Notice of Voluntary Dismissal. (JM) |
| Filing 6 NOTICE of Voluntary Dismissal by Plaintiffs Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. Without Prejudice (Zhong, Meng) |
| Filing 5 NOTICE TO COUNSEL PURSUANT TO LOCAL RULE IA 11-2. Counsel Emily R. Whelan, Kevin Prussia, Lisa J. Pirozzolo, Timothy Cook to comply with completion and filing of the Verified Petition and Designation of Local Counsel. For your convenience, click on the following link to obtain the form from the Court's website - #www.nvd.uscourts.gov. Upon approval of the Verified Petition, counsel is required to register for the Court's Case Management and Electronic Case Filing (CM/ECF) system and the electronic service of documents. Please visit the Court's website www.nvd.uscourts.gov to register Attorney. Verified Petition due by 6/29/2019. (no image attached) (JM) |
| Filing 4 AO 120 - REPORT on the filing or determination of an action regarding a patent or trademark. E-mailed to the US Patent and Trademark Office. (JM) |
| Filing 3 Summons Issued as to All Defendants. (JM) |
| Filing 2 CERTIFICATE of Interested Parties by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc. that identifies all parties that have an interest in the outcome of this case. Corporate Parent Akebia Therapeutics, Inc. for Keryx Biopharmaceuticals, Inc. added. (McCue, Michael) |
| Filing 1 COMPLAINT against Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc. (Filing fee $400 receipt number 0978-5550121) by Keryx Biopharmaceuticals, Inc., Panion & BF Biotech, Inc.. Proof of service due by 8/13/2019. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K, #12 Exhibit L, #13 Civil Cover Sheet, #14 Summons, #15 Summons, #16 Summons)(McCue, Michael) NOTICE of Certificate of Interested Parties requirement: Under Local Rule 7.1-1, a party must immediately file its disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. |
| Case randomly assigned to Judge Richard F. Boulware, II and Magistrate Judge Nancy J. Koppe. (JM) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Nevada District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
